Trial Profile
Confirmatory Study of MCC-847 for the treatment of adult asthma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Masilukast (Primary)
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 10 Jun 2016 New trial record